In the video below we highlight 4 names that have shown relative strength to the market this week and are in a prime position to see additional follow through in the coming days/weeks.
Continue Reading -->
5) Tesla Destroys Options Traders Yesterday, I opined that Tesla (TSLA) options were probably not as cheap as they looked. It turns out they were way oveprriced. As of yesterday morning, they were pricing in a $12.84 move. Tesla is down only $1.30, which is absolutely murdering holders of puts and calls. Weekly at-the-money $225 calls are down -67% while the $225 puts are down -55%. Meanwhile, sellers of the weekly $225 straddle are up an amazing 61% in one day — I wish I was in that crowd! 4) Watch Dem Bios! For the past 2 days, the SPX has looked pretty sleepy. However, relative strength in biotech (IBB,XBI) and the Russell 2000 implied more bullishness under the surface. Today, both IBB and XBI are in the red, but making little moves off the lows, even with sector heavyweight Biogen Idec (BIIB) sinking another -1.7% as takeover rumors extinguish themselves. If I was a bear, I would most definitely not want to see biotech turn green and lead again, especially since the Russell is outperforming SPX by about 30 bps. 3) Sentiment Update Sentiment is still getting more bearish. The CBOE Equity Put/Call is at 0.94 this morning, which is right in-line with the YTD average, but well off the early July lows. However, the ISE Sentiment Index is at 66 this morning (66 calls for every 100 puts). That’s a of aggressive hedging in the early going. Plus, the AAII survey shows 29.8% bulls — well below the long-term 38.6% average. Overall, it looks like traders are looking a little more skittish ahead of a pivotal NFP report tomorrow. 2) Oil Crude oil is still hugging the $40-handle pretty tightly. I’m still a bit puzzled as to how well both equities and high-yield are ignoring oil’s 20%+ drop off the highs. Take a look at this chart of crude oil vs. HYG year-to-date: Energy stocks have been slipping, but overall, the market’s basically yawning at oil weakness. Maybe folks are just rotating into metals? GLD is up 28% YTD while SLV is up 46%. Meanwhile, the miners (GDX) are up 127%! 1) Why the VIX Could Collapse Lots of traders are out saying the VIX is low, but I believe it could drop to the 10-11 range. Remember what the VIX is — a representation of volatility expectations, as measured by 30-day SPX options. With the recent lack of movement, 20-day realized SPX volatility has collapsed to 5.4. So the 12.6 VIX is actually trading at a massive premium to actual market volatility. This means it’s already pricing in an expansion in volatility. If the market continues to go flat (which I expect for the next month) — or if it climbs slowly — the VIX could easily drop below 11 as traders reprice options to reflect persistently low actual market volatility. Now with a wild move, all bets are off (we do have NFP tomorrow) — buyers of puts or call could make a lot of money. But if the markets go flat as I expect, folks buying what look like “cheap” options will find out that they overpaid. P.S. If you’re into this fancy options stuff, check out today’s FREE webinar with my buddy Doug Robertson.
Continue Reading -->
Make sure you check out Doug Robertson’s options webinar, which is scheduled for Thursday after the close. Click here for more details. 1) Biotech Looks Great The SPX and NASDAQ are basically flat, but the Nasdaq Biotech ETF (IBB) is up 0.4%. That’s pretty impressive given that Biogen Idec (BIIB) is off -3.6% today as cold water was thrown on yesterday’s takeover rumors. BIIB is 7.8% of IBB, so biotech really is doing well on this shaky dayy. The S&P Biotech ETF (XBI), which is muct more diversified, giving a better view of biotech overall, is up 0.7%. 2) Crude Oil Too Strong? I’d rather see crude oil down into today’s inventory number at 10:30 a.m. ET. Oil has acted horribly and I’d rather just see an all-out collapse of expectations ahead of the data release. Economists are pricing in a -1.75 million barrely draw. We’re about to find out if that hurdle is low enough to clear. 3) Sentiment Weakening Just a Tiny Bit The VIX is flat today, but other indicators show that traders are getting a tiny bit spooked. The CBOE equity put-call ratio is still above the YTD average and the ISE Sentiment Index shows increased demand for put options. But one thing I don’t like is that the Investors Intelligence Survey has barely budged. 52.9% of newsletter writers are bullish, down just 1% from last week. That’s still within range of II’s danger zone. On balance, I’d say that traders are still pretty complacent — just not extremely so. 4) Tesla on Tap Tesla (TSLA) reports earnings today after the close, and a few options guys are chattering that Tesla options look cheap into earnings. Tesla options are pricing in a $12.84 move, which is actually small relative to some of its recent post-earnings report reactions. But I’m not so sure the options are cheap. Tesla has recently announced a boatload of news, including a capital raise, launch of Model 3 reservations, and the SolarCity (SCTY) deal. So Tesla may not have many big ‘shockers’ left to move the stock. And when you buy options into earnings, you want a big move in your direction. So tread carefully. (by the way, if you’re into options, make sure you sign up for Doug Robertson’s webinar) 5) Respect Price As of late, we’ve seen a lot of market commentators making “what goes up must come down”-type arguments against the market. Yes, we’ve come a long way since the Brexit bottom. But that’s been for good reason. Earnings season has not been as bad as expected, and economic data has generally been pretty decent. You must always remember the biggest lesson Mr. Market likes to teach — that price trends tend to last a lot longer and go further than may seem reasonable. So always respect price… even when it seems crazy. Remember, the most important question in markets is now who, what, why, or how. It’s WHEN. A great thesis means zero without equally great timing. So avoid a rush to judgement when it comes to price.
Continue Reading -->